- Biotechnology
- Healthcare
Regeneron Pharmaceuticals, Inc.
REGN · US ·
NASDAQ
1125.72
USD
+12.37
(1.10%)
-
39.98
EPS
-
28.16
P/E
-
122B
MARKET CAP
-
0.00%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 43.1 | 48.2 | 46.8 | 59.4 | 66 | 70.6 | 10.38% |
| Avg. Estimate | 40.3 | 45.1 | 40.1 | 47.2 | 61.7 | 66 | 10.38% |
| Low Estimate | 37.7 | 41.9 | 33.6 | 38.5 | 57.7 | 61.8 | 10.38% |
| No. Of Analysts | 15 | 18 | 16 | 11 | 4 | 5 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 13.6B | 14.5B | 15.9B | 17.3B | 19B | 19.9B | 7.83% |
| Avg. Estimate | 13.5B | 14.1B | 15.3B | 16.4B | 18B | 18.9B | 6.94% |
| Low Estimate | 13.2B | 13.9B | 14.7B | 15.6B | 17.1B | 17.9B | 6.33% |
| No. Of Analysts | 18 | 17 | 20 | 22 | 12 | 10 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 5.19B | 5.48B | 5.32B | 6.75B | 7.5B | 8.03B | 9.14% |
| Avg. Estimate | 4.32B | 5.12B | 4.43B | 5.19B | 7.02B | 7.51B | 11.68% |
| Low Estimate | 3.46B | 4.77B | 3.82B | 4.38B | 6.56B | 7.02B | 15.22% |
| No. Of Analysts | 18 | 17 | 20 | 22 | 12 | 10 |